Snowball logo
logo
ACRS

Aclaris Therapeutics Inc

ACRS β€’ NASDAQ
$5.56-$0.50Β  (8.25%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
6.76129.7531.2518.727.8268.219
COGS
4.71311.9618.082.7922.0910.361
Gross Profit
2.04817.7913.1715.935.7357.858
Operating Expenses & Income
Operating Income
(89.72)(89.85)(97.36)(141.9)(76.38)(86.31)
Total Operating Expenses
91.77107.6110.5157.982.1194.17
R&D Expenses
43.8177.8198.3833.5952.6564.12
Selling General & Admin Expenses
23.6225.1331.122.221.9723.24
Earnings from Continuing Operations
Interest Expense
(23.42)(4.7)----
Interest Income
---7.9537.6376.728
Income Tax Expense
23.421.754(0.367)---
Net Income
Net Income
(90.86)(86.91)(88.48)(132.1)(64.92)(75.74)
Supplemental
EBIT
(65.38)(85.15)(116.3)(52.53)(64.92)(75.74)
EBITDA
(64.46)(84.36)(115.5)(51.72)(64.47)(75.11)
In millions of USD, except % and values per 1 share